PTGX Operating Cash Flow
Protagonist Therapeutics Inc · Operating Cash Flow
PTGX Operating Cash Flow
Latest reported$131.20Mperiod ending
PTGX TTM Operating Cash Flow (-$14.39M → $131.20M)
TTM operating cash flow
High-resolution chart · PNG
PTGX operating cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| 131,197,000 | |
| -116,635,000 | |
| 57,671,000 | |
| 65,468,000 | |
| 39,542,000 | |
| 336,944,000 | |
| 184,152,000 | |
| 230,290,000 | |
| 231,542,000 | |
| -63,318,000 | |
| -70,236,000 | |
| -118,831,000 | |
| -117,421,000 | |
| -104,818,000 | |
| -108,137,000 | |
| -103,441,000 | |
| -106,710,000 | |
| -116,775,000 | |
| -107,865,000 | |
| -99,793,000 | |
| -87,610,000 | |
| -85,392,000 | |
| -72,484,000 | |
| -67,906,000 | |
| -65,865,000 | |
| -40,713,000 | |
| -41,527,000 | |
| -37,373,000 | |
| -32,403,000 | |
| -51,471,000 | |
| -49,947,000 | |
| -53,961,000 | |
| -3,981,000 | |
| -910,000 | |
| 3,872,000 | |
| 8,341,000 | |
| -39,343,000 | |
| -35,089,000 | |
| -29,972,000 | |
| -25,031,000 | |
| -21,820,000 | |
| -17,191,000 | |
| -14,385,000 |